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Abstract
Background: Bronchoalveolar lavage (BAL) fluid cytology and culture are used to
characterize respiratory diseases in dogs. Little is known about disorders associated
with increased numbers of lymphocytes in BAL fluid.
Objective: To evaluate duration of clinical signs and detection of specific respiratory
diagnoses in dogs with BAL lymphocytosis.
Animals: One-hundred four client-owned dogs evaluated for respiratory signs.
Methods: Medical records of dogs that had >300 cells/μL and >20% lymphocytes on
a differential cell count of BAL fluid between January 1, 2006, and January 1, 2016,
were reviewed retrospectively. Cases were evaluated for the duration of clinical signs
and respiratory diagnoses, including aspiration injury, infectious or inflammatory
respiratory disease, and airway collapse.
Results: Dogs ranged in age from 0.5 to 16 years (median, 7.9 years) and had a
median body weight of 11.4 kg (range, 2.0-42.7 kg). Eosinophilic lung disease was
documented in 13 of 104 dogs (Group 1) and airway neutrophilia associated with
infectious or inflammatory disease was found in 59 of 104 dogs (Group 2). Lym-
phocytosis alone in BAL fluid was described in 32 dogs (Group 3). Duration of
cough did not differ among groups, but airway collapse was significantly more
common in dogs with solitary lymphocytosis than in those with other types of
inflammation.
Conclusions and Clinical Importance: Lymphocytosis in BAL fluid is common in dogs
and, in many cases, likely represents a common response to airway injury, indepen-
dent of the type or duration of insult. It is unknown whether airway collapse leads to
lymphocytosis or if the inflammatory process causes airway collapse.
K E YWORD S
bronchitis, bronchomalacia, eosinophilic lung disease, infection
1 | INTRODUCTION
Bronchoalveolar lavage (BAL) fluid cytology and culture are used to
characterize respiratory diseases in dogs and cats. In particular, varia-
tions in differential cell percentages in BAL fluid are used to diagnoseAbbreviations: BAL, bronchoalveolar lavage; TNCC, total nucleated cell count.
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inflammatory diseases such as eosinophilic lung disease and chronic
bronchitis, and findings of degenerate neutrophils in BAL cytology
along with neutrophils containing bacteria are used to make a diagno-
sis of pneumonia. Eosinophilic lung disease is a well-defined but
poorly understood chronic respiratory disease associated with airway
and pulmonary infiltration by eosinophils and consequent bronchiec-
tasis or airway collapse.1–4 Chronic bronchitis is typified by increased
BAL fluid neutrophils in the absence of demonstrable intracellular bac-
teria and growth of pathogens in culture.5,6 It also can be associated
with bronchiectasis or airway collapse.4 Therefore, both eosinophilic
and neutrophilic inflammatory conditions are sometimes found con-
currently with bronchomalacia. With the exception of pulmonary
lymphoma,7 little is known about the clinical relevance or underlying
disease processes associated with an increased percentage of lympho-
cytes in BAL fluid.
Interpretation of BAL fluid is hampered by variations in the collec-
tion and analytical technique used by individual clinicians and labora-
tories as well as inherent variability in BAL fluid cytology across
multiple lung lobes in animals with respiratory disease. Multi-segment
lavage resulted in different cytologic interpretations in 1 of 3 of dogs
with diffuse disease and in almost half of the population of cats evalu-
ated.8,9 Determining a final respiratory diagnosis requires interpreta-
tion of cytologic results in conjunction with clinical and radiographic
findings.
In our hospital, BAL fluid lymphocytosis has been observed in
dogs evaluated for various respiratory diseases, but little information
is available in the literature to guide interpretation of this finding.
Lymphocytic airway inflammation has been reported in dogs with air-
way collapse in the presence or absence of left atrial enlargement,10,11
although a separate study did not report BAL fluid lymphocytosis in
any dog with bronchomalacia.12 The purpose of our study was to iden-
tify dogs with unequivocal BAL fluid lymphocytosis and to determine
underlying etiologic causes associated with lymphocytic airway inflam-
mation. Based on our clinical experience, we hypothesized that dogs
with BAL fluid lymphocytosis alone would have longer duration of
cough and increased detection of bronchomalacia in comparison to
dogs with concurrent eosinophilic or neutrophilic airway inflammation.
2 | MATERIALS AND METHODS
Medical records at the William R. Pritchard Veterinary Medical Teach-
ing Hospital at the University of California, Davis, were searched for
all dogs that had bronchoscopy performed between January 1, 2006,
and January 1, 2016. The endobronchial tree was evaluated in stan-
dard fashion, and site(s) for BAL were chosen by the endoscopist
based on radiographic and bronchoscopic findings. The endoscope
was withdrawn from the airway to irrigate the channel and wipe con-
taminating material from the exterior of the scope. The endoscope
was wedged into the smallest airway possible followed by instillation
and aspiration of warm, sterile saline through the biopsy channel of
the endoscope. Lavage volume was based on the size of the dog, the
outer diameter of the bronchoscope used, and the ability to wedge
the bronchoscope in the airway in a way that provided adequate
return. A rough guideline of 1 mL/kg/lavage site as a single aliquot
was utilized, and 1 to 4 sites were lavaged as clinically indicated.
Lavages from distinct lobar sites were processed within 1 hour of col-
lection and were examined separately for cytologic analysis by board-
certified clinical pathologists. Total nucleated cell counts (TNCC) were
performed on unfiltered BAL fluid using an automated cell counter
(Advia 120; Siemens, Deerfield, Illinois) and reported as TNCC/μL.
Slides were prepared for cytologic analysis by cytocentrifugation
(Cytospin3; ThermoShandon, Pittsburgh, Pennsylvania) followed by
Wright-Giemsa staining using an automated cell stainer (Model 7151
Wescor Aerospray Hematology Pro; ELITech Bio-Medical Systems,
Logan, Utah). A differential cell count was based on an assessment of
200 cells.
Normal reference values used for canine BAL fluid differential cell
counts in our laboratory are approximately 80% macrophages, 7%
lymphocytes, 5% neutrophils, 6% eosinophils, 1% mast cells, and 1%
epithelial cells in dogs.13 Samples with a TNCC <300 cells/μL were
excluded from analysis to ensure that a representative sample of epi-
thelial lining fluid had been obtained. For the purposes of our study,
bronchoalveolar cytology reports were searched for dogs that had a
lymphocyte differential count >20% from at least 1 lavage site, and all
dogs were included in the study regardless of previous medication
administered or coincident diseases other than neoplasia. Cases were
further segregated into those that had concurrent airway eosinophilia
(Group 1) defined as >14% eosinophils from at least 1 lavage site (rep-
resenting >90th percentile for this cell type determined in a BAL study
of dogs with histologically normal lungs)13 and dogs with airway neu-
trophilia >8% from at least 1 lavage site (Group 2), for comparison
with dogs that had airway lymphocytosis in the absence of increases
in other inflammatory cell types (Group 3).
A pooled sample of BAL fluid was plated onto 5% sheep blood
agar and MacConkey's agar for isolation of aerobic organisms and
onto pleuropneumonia-like organism base with thallium acetate (anti-
fungal) and penicillin G (antibacterial) for Mycoplasma spp. isolation. At
the discretion of the clinician, a pooled sample also was plated onto
pre-reduced anaerobic Brucella plates (Anaerobe Systems, Morgan
Hill, California) for anaerobic culture and onto inhibitory mold agar
(Hardy Diagnostics, Santa Maria, California) for fungal culture. Micro-
bial growth was assessed in a semi-quantitative fashion by counting
the number of quadrants with growth and reported as 1+, 2+, 3+, or
4+. Standard biochemical methods were used to identify cultured
bacteria.
Data abstracted from the medical record included age, breed, and
sex, type and duration of clinical signs, and previous antimicrobial or
glucocorticoid treatment within the past week. Underlying respiratory
disease processes associated with airway lymphocytosis were diag-
nosed based on bronchoscopic findings and ancillary tests, including
radiologic or tomographic findings, airway culture, fecal evaluations,
serologic testing, and response to treatment. Dogs with neoplasia
were excluded from the study. Specific respiratory diagnoses and the
criteria used to assign the diagnosis are listed in Table 1.
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2.1 | Statistical analysis
Data were assessed for normality using the D'Agostino & Pearson
omnibus normality test. (GraphPad Prism version 5.0f) Normally dis-
tributed data are presented as mean ± SD, and statistical evaluation
among groups was performed using analysis of variance followed by
post hoc comparisons between groups using Tukey's test. Data with a
non-Gaussian distribution are presented as median with range. Non-
parametric data were assessed using the Mann-Whitney U test with
Dunn's multiple comparisons for post hoc testing. The effect of age
on TNCC and percent lymphocytes was assessed by linear regression.
A chi-square test was used to compare the frequency of airway infec-
tion, airway collapse, and aspiration injury among groups. For all ana-
lyses, significance was set at P < .05.
3 | RESULTS
Between January 1, 2006, and January 1, 2016, bronchoscopy with
BAL was performed on 569 dogs. Lymphocytosis >20% was found in
BAL fluid from at least 1 lavage site in 123 dogs. In 19 of 123 dogs
(15%), TNCC was <300/μL, and those dogs were excluded from fur-
ther analysis. Dogs with BAL fluid lymphocytosis ranged in age from
0.5 to 16 years (median, 7.9 years) and had a median body weight of
11.4 kg (range, 2.0-42.7 kg). The study population comprised 6 intact
female dogs, 45 spayed females, 7 intact males, and 46 neutered male
dogs. Cough was the presenting complaint in 91 of 104 dogs (88%)
with duration between the onset of this sign and bronchoscopic
evaluation ranging from 1 day to 8 years (median, 7 months). The
remaining dogs were presented for combinations of exercise intoler-
ance, wheezing, and tachypnea or excessive panting. Antimicrobials
had been administered to 21 dogs, and 3 dogs had received glucocor-
ticoids within the week before evaluation. Median BAL fluid lympho-
cyte percentage for all dogs was 25% (range, 20%-52%), and median
TNCC was 900 cells/μL (range, 300-17 660 cells/μL).
Bronchoalveolar lavage fluid lymphocytosis with concurrent eosin-
ophilia >14% was documented in 13 of 104 dogs (12%), assigned to
Group 1. Concurrent airway neutrophilia >8% was recorded in 59 of
104 dogs (57%, Group 2), and lymphocytic inflammation alone was
present in 32 of 104 dogs (31%) comprising Group 3. Age and sex did
not differ among the 3 groups, but body weight was significantly
higher in Group 1 dogs (24 kg; range, 5.4-40.4 kg) than in Group
2 (10.7 kg; range, 2-42.7 kg) and Group 3 (9.5 kg; range, 2.3-36.2 kg;
P = .03; Table 2). Median TNCC/μL and median percentage of lym-
phocytes did not differ among groups. Total nucleated cell count and
percent lymphocytes were not correlated with age (P = .35 and .07
respectively; data not shown).
In Group 1 dogs (n = 13), median BAL fluid eosinophilia was 30%
(range, 15%-49%) with TNCC ranging from 400 to 5400/μL (median,
1030/μL). Lymphocytes in BAL fluid ranged from 20% to 36% (median,
25%). Concurrent BAL fluid neutrophilia >8% was present in 6/13
Group 1 dogs. Microbial cultures identified 1-3 colonies of bacteria in
4/13 dogs, in combination with rare Aspergillus colonies in 1 dog. No
dog was treated with antimicrobial agents, and all dogs in Group
1 responded to treatment for eosinophilic lung disease. Aspiration injury
was not suspected in any of the dogs in Group 1, but airway collapse
was identified bronchoscopically in 2 of 13 dogs.
In Group 2 dogs (n = 59), BAL fluid neutrophilia ranged from 2%
to 59% (median, 12%) and median TNCC in BAL fluid was 940 cells/
μL (range, 300-17,660 cells/μL). Lymphocyte percentages in BAL fluid
from Group 2 dogs ranged from 20% to 52% (median, 26%). Infectious
lower respiratory tract disease was documented in 14 dogs as a result
of bacterial infection (n = 9), coccidioidomycosis (n = 2), Pneumocystis
canis (n = 1), and foreign body pneumonia (n = 2). Bordetella
TABLE 1 Clinical criteria used to establish individual respiratory
diagnoses
Respiratory diagnosis Criteria
Pneumonia
Bacterial Historical and clinical findings in
conjunction with compatible
radiographic changes and airway
sepsis (intracellular bacteria
observed cytologically or positive
growth of potential pathogens on
culture)
Fungal Positive serology for
coccidioidomycosis with compatible
clinical and radiographic findings or
identification of Pneumocystis canis
cysts on BAL cytology or with PCR
and sequencing
Foreign body Bronchoscopic identification of
foreign material
Eosinophilic lung disease BAL eosinophils >14%
Negative Baermann fecal examination
or failure to respond to
fenbendazole (50 mg/kg
PO × 10 days)
Therapeutic response to steroids
Chronic bronchitis Cough duration >2 months
BAL neutrophils >8%
Lack of intracellular bacteria on
cytologic assessment or no bacterial
growth on culture
Lymphocytic inflammatory
airway disease
BAL lymphocytes >20% with
eosinophils <14% and neutrophils
<8%
Airway collapse
Tracheomalacia
Tracheobronchomalacia
Bronchomalacia
Bronchoscopy demonstrating >50%
collapse of the airway lumen
Aspiration injury History of antibiotic responsive
pneumonia, middle or cranioventral
pulmonary infiltrates, presence of
risk factors for aspiration including
laryngeal paresis or paralysis,
esophageal disease, brachycephalic
obstructive airway syndrome
Abbreviations: BAL, bronchoalveolar lavage; PCR, polymerase chain reaction.
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bronchiseptica was isolated from 4 of 9 dogs with lower respiratory
tract infection in this group, as the sole pathogen in 2 dogs and in
combination with mixed growth in 2 dogs. All dogs with bordetellosis
were <1 year of age. Interstitial pneumonia and thromboembolic dis-
ease were suspected in 1 dog each. Chronic bronchitis with or with-
out airway collapse was diagnosed in 23 dogs, and airway collapse
alone was noted in 8 dogs. In total, airway collapse was documented
bronchoscopically in 21 of 59 dogs. Aspiration injury was suspected in
9 dogs, and a diagnosis was undetermined in 3 dogs presented for
exercise intolerance.
Lymphocytosis in BAL fluid >20% in the absence of other inflam-
mation was documented in 32 of 104 dogs (31%) in Group 3. Age of
affected dogs ranged from 0.5 to 16 years (median, 7 years) and
median body weight was 9.5 kg (range, 2.3-36.2 kg), with 6 dogs
<5 kg, 12 dogs 5-10 kg, 5 dogs 10-20 kg, and 9 dogs >20 kg. Cough
was the presenting complaint in 30 of 32 dogs with duration ranging
from 1 day to 5 years (median, 9 months) from the onset of clinical
signs to bronchoscopic evaluation. Reverse sneezing and exercise
intolerance were reported in the remaining 2 dogs. Median lympho-
cyte percentage was 24% (range, 20%-43%) and TNCC ranged from
320 to 2300 cells/μL (median, 680 cells/μL). Total nucleated cell count
per microliter and the percentage of lymphocytes did not differ from
that found in Group 1 and Group 2 dogs (P = .09 and .18, respec-
tively). No intracellular bacteria were observed cytologically in any
dog, but Bordetella bronchiseptica infection was confirmed in 2 dogs,
both of which were <1 year of age.
Cough was the most prominent clinical finding in our study, and
the duration of cough did not differ among groups. (Table 3) Airway
collapse was identified in 19 of 32 (59%) of Group 3 dogs and was sig-
nificantly more common than in Group 1 (2/13, 15%) and Group
2 dogs (21/59, 36%; P = .006). Aspiration injury was diagnosed clini-
cally in a total of 17 dogs in Groups 2 and 3. Eight of these dogs, 2 of
which also had bronchomalacia, were in Group 3, and the proportion
of dogs diagnosed with aspiration injury did not differ from that in
Group 2 dogs (P = .27). The number of dogs treated with antimicro-
bials or glucocorticoids did not differ among groups.
In 6 dogs from Group 3, a specific disease process accompanying
airway lymphocytosis was not identified. These dogs ranged in age
from 1 to 11.5 years (median, 3.2 years) and 5 of 6 dogs presented
for cough, ranging in duration from 9 months to 5 years (median,
12 months). One dog presented for exercise intolerance and a specific
etiology was not determined. In the 5 dogs with cough, 1 had primary
ciliary dyskinesia diagnosed by scintigraphy and 3 dogs had concur-
rent inflammatory rhinitis. The TNCC in BAL fluid ranged from 440 to
1660/μL (median, 820/μL) with 20%-33% lymphocytes (median, 26%).
4 | DISCUSSION
Bronchoalveolar lavage fluid lymphocytosis >20% of the differential
cell count was a common finding in dogs evaluated for respiratory dis-
ease during this 10-year period, affecting approximately 20% of dogs
TABLE 2 Demographic and bronchoalveolar lavage data in dogs with BAL fluid lymphocytosis that had concurrent BAL fluid eosinophilia
(Group 1), neutrophilia (Group 2), and lymphocytosis alone (Group 3)
Group 1 (n = 13) Group 2 (n = 59) Group 3 (n = 32) P
Age (years) 7 (1-13) 8 (0.7-14) 7 (0.5-16) .81
Weight (kg) 24 (5.4-40.4)* 10.7 (2.0-42.7) 9.5 (2.3-36.2) .03
Male/female 4/9 29/30 13/19 NA
TNCC/μL 1060 (400-5400) 940 (300-17 660) 680 (320-2300) .09
BAL fluid % lymphocytes 26 (20-36) 26 (20-52) 24 (20-43) .25
BAL fluid % neutrophils 9.2 ± 7.1 12 (2-59) 5 (1-8) NA
BAL fluid % eosinophils 30 (15-49) 3 (0-14) 3 (0-14) NA
Abbreviations: BAL, bronchoalveolar lavage; TNCC, total nucleated cell count.
*Indicates that the table entry is significantly different from others within the same row.
TABLE 3 Clinical features and diagnoses in dogs with BAL fluid lymphocytosis associated with eosinophilia (Group 1), neutrophilia (Group 2),
and lymphocytosis alone (Group 3)
Group 1 (n = 13) Group 2 (n = 59) Group 3 (n = 32) P
Cough 11/13 50/59 30/32 NA
Cough duration before bronchoscopy (months) 9 (1-24) 4.5 (0.03-96) 9 (0.1-60) .28
Antimicrobials within 1 week of bronchoscopy 1/13 14/59 6/32 .41
Glucocorticoids within 1 week of bronchoscopy 0/13 0/13 3/21 NA
Infection 0/13 14/59* 2/32 .02
Airway collapse 2/13 21/59 19/32* .006
Aspiration injury 0/13 9/59 8/32 .56
Abbreviations: BAL, bronchoalveolar lavage; NA, not available because conditions for chi-square analysis have not been met (values <1).
*Indicates that the table entry is significantly different from others within the same row.
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undergoing bronchoscopy. We chose a cutoff of >20% lymphocytes
to create an unequivocal definition of an abnormal increase. Although
our laboratory uses <7% BAL fluid lymphocytes to define normal
cytology,13–15 others have suggested that up to 14% lymphocytes can
be identified in BAL fluid from normal dogs. 16 A more strict definition
of BAL fluid lymphocytosis might have required BAL fluid lymphocy-
tosis from >1 lavage site. However, given the paucity of information
on BAL fluid lymphocytosis, our study was designed to evaluate the
largest cohort of dogs possible. Therefore, unequivocal BAL fluid lym-
phocytosis in at least 1 lavage sample was the selected criterion.
Our study identified a variety of disease processes associated with
BAL fluid lymphocytosis in dogs, suggesting that lymphocytes could
play a key role in the response to airway injury, regardless of the etiol-
ogy of disease. In people, increased BAL fluid lymphocytes can be
observed in asthma, sarcoidosis, infectious diseases such as human
immunodeficiency virus and tuberculosis, lung neoplasia, bronchiolitis,
and hypersensitivity lung diseases associated with eosinophilia.17 In
horses, BAL fluid lymphocytosis also can be associated with various
respiratory disease processes,18 likely because lymphocytes in the sur-
face epithelium are involved in both protective immunity against
infectious agents and immune responses to inhaled antigens. An
unrecognized virus, pathogen, or irritant could have been responsible
for BAL fluid lymphocytosis in some dogs examined here. The BAL
fluid was markedly hypercellular in most cases in our study, which
implies a concurrent increase in total macrophage numbers in airway
fluid as well as lymphocytes. Macrophages also are responsible for
identification and removal of intracellular pathogens and particulate
antigens.19
Twelve percent of dogs with BAL fluid lymphocytosis had con-
current eosinophilia >14%. Increased lymphocytes are expected in
dogs with eosinophilic lung disease, because cytokines produced by
lymphocytes play a role in triggering IgE production and attracting
eosinophils in Th2 hypersensitivity type disease. In humans with
hypersensitivity pneumonitis, BAL fluid lymphocytosis was always
present in the acute phase of disease (first 3-8 weeks)20 although not
always later in the course of disease. In a separate study of eosino-
philic lung disease in 86 dogs, encompassing the same time frame as
our study, BAL fluid lymphocytosis >20% was present in only 5 of
86 dogs.21 It is possible that lymphocytes are present only in the early
stage of hypersensitivity-type lung disease in dogs and decrease with
chronicity, although this possibility was not examined specifically
here. Interestingly, in humans, hypersensitivity pneumonitis can result
in BAL fluid lymphocytosis approaching 80% of the differential cytol-
ogy, yet BAL fluid eosinophilia might be found in only half of these
individuals.20 This possibility has not been examined in dogs. In nor-
mal dogs, the CD4 :CD8 ratio of airway T lymphocytes is 1.3,16 which
is similar to that found in normal humans. Eosinophilic lung disease in
dogs is associated with a dramatic increase in the BAL fluid lympho-
cyte CD4 :CD8 ratio because of a large increase in CD4 cells,2 consis-
tent with the observation of concurrent increases in both BAL fluid
eosinophils and lymphocytes in dogs with eosinophilic airway disease.
T-cell subtypes alterations in BAL fluid were not examined here and
have not been evaluated in other respiratory diseases of dogs.
Concurrent neutrophilic inflammation was the most common find-
ing in dogs examined here, with bacterial infection identified in 9 of
59 dogs. In a study of bacterial pneumonia in dogs, BAL fluid lympho-
cytes approached 20% of the differential cell count.22 In experimental
studies of humans, lipopolysaccharide inhalation caused a 100-fold
increase in airway neutrophils but also increased lymphocytes 3-fold.23
Therefore, although bacterial airway diseases are anticipated to result
in neutrophilic inflammation, it is not unexpected to observe concur-
rent lymphocytosis in some instances. Th17 T-cells are a subset of
CD4+ T helper cells, and a Th17 response can recruit neutrophils as a
result of IL17 induction of IL-8 production.24 Th17 cytokines can play
a protective role against pathogens but also can induce pathology.
Interleukin 17 recruits neutrophils in response to Klebsiella challenge25
and Streptococcus infection26 as well as fungal invasion. Th17 cyto-
kines might serve as a bridge between innate and adaptive immune
responses in the host defense against a variety of extracellular patho-
gens at mucosal surfaces.27 However, many Group 2 dogs that had
both neutrophilia and lymphocytosis in BAL fluid did not have a
demonstrable infectious component of disease. This observation might
suggest a host-driven Th17-dominant immune response to a variety of
antigens, as has been suggested in both allergic skin disease and allergic
lung disease in people, including asthma.28 The discovery of new cyto-
kines and T-cell subsets that play a role in shaping inflammatory
responses has resulted in evolution of the classical Th-1/Th-2 para-
digm. Interleukin 17 clearly plays a role in the induction and mainte-
nance of hypersensitivity responses long considered as solely Th-1/
Th-2-mediated disorders.28
Aspiration injury was found in dogs with both neutrophilic and
lymphocytic inflammation as well as solely lymphocytic inflammation
in BAL fluid. Aspiration injury is thought to trigger a Th17 response as
part of the immune response to inhalation of pathogens or irritant
material,29 and microaspiration has been proposed to play an impor-
tant role in a number of respiratory diseases in dogs.30,31 In children,
both strongly and weakly acidic chemical insults resulted in increased
BAL fluid neutrophils and increased lymphocytes, indicating a non-
specific response to airway injury.32 It is unclear why some dogs in
our study developed mixed inflammation rather than purely lympho-
cytic inflammation, but it might reflect a disease process more similar
to aspiration pneumonitis in some dogs versus the neutrophilic response
of aspiration pneumonia in other dogs.
In the group of dogs examined here, a relatively large number
(31%, Group 3) had isolated BAL fluid lymphocytosis. Airway collapse
was common in this group of dogs and was found more often in
Group 3 dogs than in dogs with other types of airway inflammation. It
is possible that cartilage degeneration associated with airway collapse
results in release of antigenic material, triggering lymphocytic inflam-
mation. In dogs with intervertebral disk herniation, leakage of antigens
from the nucleus pulposus is proposed to be the etiology of cerebro-
spinal fluid lymphocytic inflammation that is common in this disease.33
In dogs with left atrial enlargement associated with myxomatous
mitral valve disease and concurrent bronchomalacia, BAL fluid lym-
phocytosis was present in 4 of 10 cases.11 However, in a guinea pig
model of airway collapse induced by negative pressure applied to the
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airway, the inflammatory response was neutrophilic and macrophagic.34
In dogs with bronchomalacia, it is unknown whether collapse leads to
inflammation or inflammation perpetuates collapse. As stated previ-
ously, BAL fluid was markedly hypercellular in most instances in our
study, which implies a concurrent increase in total macrophage num-
bers in lymphocytic airway fluid. Increased BAL fluid lymphocytes and
macrophages might represent a predominantly Th-1 type response to
viral pathogens or local or inhaled antigens, with sequelae that include
bronchomalacia and airway collapse.
Interestingly, 6 dogs with BAL fluid lymphocytosis in our study
were diagnosed with Bordetella infection, 4 of which also had concur-
rent airway neutrophilia. All 6 dogs were <1 year of age. Although
concurrent viral infection might explain lymphocytosis in these dogs,
it has not been found previously in dogs with bordetellosis. 22 Another
explanation for the BAL fluid lymphocytosis in these 6 young dogs is
physiologic lymphocytosis. No specific data are available on normal
values for BAL fluid differential cytology of dogs <1 year of age. In
healthy Beagle dogs, age affects BAL fluid lymphocyte percentages
with younger (<5 years) and older (>8 years) animals having 5%-6%
BAL fluid lymphocytes in comparison to 1% lymphocytes in dogs
5-8 years of age.15 Curiously, BAL fluid lymphocyte percentages
increase with age in healthy humans and horses,18,35 with markedly
increased BAL fluid lymphocytes in adult horses (46%) compared to
foals (3%-5%).18 We found no effect of age on BAL fluid lymphocytes,
but young dogs have higher blood lymphocyte counts than do older
dogs. These varied findings suggest the need to define age-specific
normal values and perhaps to investigate potential differences in dog
breeds or type.
We hypothesized that dogs with BAL fluid lymphocytosis alone
would have both longer duration of cough and increased detection of
airway collapse in comparison to dog with concurrent eosinophilic or
neutrophilic airway inflammation. Although the latter was true, dura-
tion of cough did not differ among groups of dogs with various types
of airway inflammation. Our original hypothesis was partly based on
the notion that acute inflammation often is associated with influx of
neutrophils, whereas chronic inflammation more often is associated
with lymphoplasmacytic infiltrates. In retrospect, this hypothesis was
clearly naive. Lymphocytosis in BAL fluid can occur with acute airway
inflammation,20 and lymphocytes play a pivotal role in airway inflam-
matory responses in all phases and at all stages.
Prior administration of antimicrobial agents did not have an effect
on BAL fluid lymphocytosis detected here because equal numbers of
dogs in each group had received these drugs in the week before bron-
choscopy. A relatively low number of dogs received glucocorticoids in
the week before bronchoscopy, which also did not appear to play a role
in the cytologic findings identified here. Interestingly, BAL fluid lympho-
cytosis was identified in 3 of 21 dogs despite corticosteroid use.
The retrospective nature of our study is a limitation to interpreta-
tion of results. None of the dogs had BAL fluid submitted for viral
screening or assessment of novel pathogens that might have contrib-
uted to lymphocytosis. Our clinical pathology laboratory routinely per-
forms differential cytology on a count of 200 cells; however, 1 study
indicated that this methodology does not provide reproducible results
between observers for lymphocyte identification.36 Finally, we elected
to include all cases that had at least 1 BAL site with >20% lympho-
cytes. A prospective study should aim to collect 3 lavages sites to be
able to confirm increased lymphocyte percentages in a majority of
samples, and the differential cell count should be performed on
500 cells.
We have characterized BAL fluid lymphocytosis in a large cohort of
dogs with respiratory disease and determined some disease associations.
Further research is required, including defining a discrete population of
affected dogs and determining the lymphocyte subsets and cytokine
profiles associated with both BAL fluid lymphocytosis alone and BAL
fluid lymphocytosis with concurrent eosinophilia and neutrophilia.
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